Relmada Therapeutics, Inc. (RLMD)
4.52
+0.45
(+11.06%)
USD |
NASDAQ |
Sep 11, 16:00
4.62
+0.10
(+2.21%)
After-Hours: 20:00
Relmada Therapeutics Shareholders Equity (Quarterly) : 206.56M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 206.56M |
| March 31, 2026 | 218.73M |
| December 31, 2025 | 86.51M |
| September 30, 2025 | 9.466M |
| June 30, 2025 | 15.95M |
| March 31, 2025 | 22.44M |
| December 31, 2024 | 35.52M |
| September 30, 2024 | 47.63M |
| June 30, 2024 | 61.49M |
| March 31, 2024 | 72.05M |
| December 31, 2023 | 85.36M |
| September 30, 2023 | 100.73M |
| June 30, 2023 | 111.34M |
| March 31, 2023 | 125.47M |
| December 31, 2022 | 140.44M |
| September 30, 2022 | 166.34M |
| June 30, 2022 | 196.85M |
| March 31, 2022 | 210.40M |
| December 31, 2021 | 208.26M |
| September 30, 2021 | 72.69M |
| June 30, 2021 | 96.85M |
| March 31, 2021 | 91.15M |
| December 31, 2020 | 105.58M |
| September 30, 2020 | 122.21M |
| June 30, 2020 | 132.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 113.16M |
| June 30, 2019 | 7.613M |
| March 31, 2019 | 0.4739M |
| December 31, 2018 | 1.435M |
| September 30, 2018 | -8.740M |
| June 30, 2018 | -5.513M |
| March 31, 2018 | -2.316M |
| December 31, 2017 | 0.7212M |
| September 30, 2017 | 1.465M |
| June 30, 2017 | 1.460M |
| March 31, 2017 | 2.802M |
| December 31, 2016 | 4.675M |
| September 30, 2016 | 5.574M |
| June 30, 2016 | 7.042M |
| March 31, 2016 | 10.20M |
| December 31, 2015 | 11.76M |
| September 30, 2015 | 13.84M |
| June 30, 2015 | 8.810M |
| March 31, 2015 | 2.494M |
| December 31, 2014 | 4.593M |
| September 30, 2014 | -20.72M |
| August 31, 2014 | |
| May 31, 2014 | |
| February 28, 2014 | -0.0312M |
| September 30, 2013 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 219.06M |
| Total Liabilities (Quarterly) | 12.50M |
| Current Ratio | 29.52 |